Compounds > n-methyl-3,4-methylenedioxyamphetamine

n-methyl-3,4-methylenedioxyamphetamine and ergoline

n-methyl-3,4-methylenedioxyamphetamine has been researched along with ergoline in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiodo, LA; Freeman, AS; Kelland, MD1
Gudelsky, GA; Nair, SG1
Bhattacharyya, S; Davar, J; Mikhailidis, DP; Schapira, AH1
Cosyns, B; Droogmans, S; Lancellotti, P; Rosenhek, R1

Reviews

2 review(s) available for n-methyl-3,4-methylenedioxyamphetamine and ergoline

ArticleYear
Drug-induced fibrotic valvular heart disease.
    Lancet (London, England), 2009, Aug-15, Volume: 374, Issue:9689

    Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Monitoring; Ergolines; Ergotamine; Fenfluramine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Methysergide; Migraine Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Patient Selection; Pergolide; Receptors, Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Vasoconstrictor Agents

2009
Drug-induced valvular heart disease.
    Heart (British Cardiac Society), 2013, Volume: 99, Issue:1

    Topics: Dopamine Agonists; Ergolines; Global Health; Heart Valve Diseases; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease; Prevalence; Serotonin Agents

2013

Other Studies

2 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and ergoline

ArticleYear
(+/-)-3,4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons.
    European journal of pharmacology, 1989, Oct-04, Volume: 169, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Apomorphine; Biogenic Amines; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Quinpirole; Rats; Rats, Inbred Strains; Serotonin; Substantia Nigra

1989
3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex.
    Synapse (New York, N.Y.), 2005, Dec-15, Volume: 58, Issue:4

    Topics: 4-Aminobenzoic Acid; Acetylcholine; Animals; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Hallucinogens; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; para-Aminobenzoates; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Serotonin, 5-HT4; Serotonin Antagonists

2005